MK0217A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MK0217A, covering 2011-08-15 to 2014-11-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) [Phase 3]